Merrimack Pharmaceuticals Announces Changes to Board of Directors
(WorldNews Health)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals (Nasdaq:MACK) (the `Company` or `Merrimack`) announced today that, effective immediately, its Board of Directors has appointed Noah G. Levy, of Newtyn Management, LLC (`Newtyn`) and Eric D. Andersen, of Western Standard, LLC (`Western`) to the Board, pursuant to a cooperation agreement. Including Messrs. Levy and Andersen, the Board will nominate five directors for election at the 2019 Annual Meeting of Shareholders (the `2019 Annual ......